Clinical Trial Update: Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial updating the combination of PD-1 and VEGFR-2 blockade for advanced hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PD-1 blockade
• VEGFR-2 blockade

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Progress Free Survival (PFS) and Overall Survival (OS) | Phase 2 | Status: COMPLETED